Literature DB >> 16523352

[The psychopathology of depersonalization].

K Oka1.   

Abstract

In his classic overview, Mayer-Gross indicated two clinical features of depersonalization to be taken as starting points for future investigation: excessive difficulty in describing it and its relatively rare appearance in organic disorders. Neither characteristic has so far been discussed sufficiently in psychopathology and neurobiology. In this article, we examine the language aspect of depersonalization by comparisons with aphasia, in which the two objects of study described by Mayer-Gross, speech and organic disorders, intertwine. Concerning amnestic aphasia, Gelb and Goldstein insist that an object cannot be grasped as a generally understood fact using a categorical attitude but only experienced subjectively in its this-ness with a concrete attitude. The particular experience of depersonalization is the reverse of that in amnestic aphasia, as the relation of the depersonalized patient to this-ness is disturbed but an ideal view of the generality remains.

Entities:  

Mesh:

Year:  2006        PMID: 16523352     DOI: 10.1007/s00115-006-2066-2

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  4 in total

1.  [Studies on depersonalization. II. Depersonalization and obsession as polar disorders of the relations of the ego and the external world].

Authors:  J E MEYER
Journal:  Psychiatr Neurol (Basel)       Date:  1957 Jan-Feb

2.  Pierre Janet and the breakdown of adaptation in psychological trauma.

Authors:  B A van der Kolk; O van der Hart
Journal:  Am J Psychiatry       Date:  1989-12       Impact factor: 18.112

Review 3.  Depersonalization: neurobiological perspectives.

Authors:  M Sierra; G E Berrios
Journal:  Biol Psychiatry       Date:  1998-11-01       Impact factor: 13.382

4.  [A contribution to the psychopathology of obsessive-compulsive disorder].

Authors:  K Oka
Journal:  Nervenarzt       Date:  2004-01       Impact factor: 1.214

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.